Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma

NCT00101010 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: Filgrastim
BIOLOGICAL: Pegfilgrastim
BIOLOGICAL: Rituximab
DRUG: Cyclophosphamide
DRUG: Pegylated liposomal doxorubicin hydrochloride
DRUG: Prednisone
DRUG: Vincristine Sulfate

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]